» Articles » PMID: 31964861

Mechanisms Governing the Pioneering and Redistribution Capabilities of the Non-classical Pioneer PU.1

Abstract

Establishing gene regulatory networks during differentiation or reprogramming requires master or pioneer transcription factors (TFs) such as PU.1, a prototype master TF of hematopoietic lineage differentiation. To systematically determine molecular features that control its activity, here we analyze DNA-binding in vitro and genome-wide in vivo across different cell types with native or ectopic PU.1 expression. Although PU.1, in contrast to classical pioneer factors, is unable to access nucleosomal target sites in vitro, ectopic induction of PU.1 leads to the extensive remodeling of chromatin and redistribution of partner TFs. De novo chromatin access, stable binding, and redistribution of partner TFs both require PU.1's N-terminal acidic activation domain and its ability to recruit SWI/SNF remodeling complexes, suggesting that the latter may collect and distribute co-associated TFs in conjunction with the non-classical pioneer TF PU.1.

Citing Articles

Regulatory Roles of SWI/SNF Chromatin Remodeling Complexes in Immune Response and Inflammatory Diseases.

Sun S, Chen Y, Ouyang Y, Tang Z Clin Rev Allergy Immunol. 2025; 68(1):2.

PMID: 39751934 DOI: 10.1007/s12016-024-09011-4.


Histone methyltransferase SETDB1 safeguards mouse fetal hematopoiesis by suppressing activation of cryptic enhancers.

Kazerani M, Cernilogar F, Pasquarella A, Hinterberger M, Nuber A, Klein L Proc Natl Acad Sci U S A. 2024; 121(52):e2409656121.

PMID: 39689172 PMC: 11670114. DOI: 10.1073/pnas.2409656121.


Redistribution of PU.1 partner transcription factor RUNX1 binding secures cell survival during leukemogenesis.

Bender A, Boydere F, Jayavelu A, Tibello A, Konig T, Aleth H EMBO J. 2024; 43(24):6291-6309.

PMID: 39543396 PMC: 11649769. DOI: 10.1038/s44318-024-00295-y.


Short circuit: Transcription factor addiction as a growing vulnerability in cancer.

Davies M, Boyce M, Conway E Curr Opin Struct Biol. 2024; 89:102948.

PMID: 39536500 PMC: 11614577. DOI: 10.1016/j.sbi.2024.102948.


Pharmacologic Blockade of a Pioneer Transcription Factor.

Cermakova K, Hodges H Cancer Res. 2024; 84(24):4124-4125.

PMID: 39476188 PMC: 11866459. DOI: 10.1158/0008-5472.CAN-24-3957.


References
1.
Choukrallah M, Matthias P . The Interplay between Chromatin and Transcription Factor Networks during B Cell Development: Who Pulls the Trigger First?. Front Immunol. 2014; 5:156. PMC: 3990105. DOI: 10.3389/fimmu.2014.00156. View

2.
Heinz S, Romanoski C, Benner C, Glass C . The selection and function of cell type-specific enhancers. Nat Rev Mol Cell Biol. 2015; 16(3):144-54. PMC: 4517609. DOI: 10.1038/nrm3949. View

3.
Friedman A . Transcriptional control of granulocyte and monocyte development. Oncogene. 2007; 26(47):6816-28. DOI: 10.1038/sj.onc.1210764. View

4.
Willis S, Tellier J, Liao Y, Trezise S, Light A, ODonnell K . Environmental sensing by mature B cells is controlled by the transcription factors PU.1 and SpiB. Nat Commun. 2017; 8(1):1426. PMC: 5681560. DOI: 10.1038/s41467-017-01605-1. View

5.
Feng R, Desbordes S, Xie H, Tillo E, Pixley F, Stanley E . PU.1 and C/EBPalpha/beta convert fibroblasts into macrophage-like cells. Proc Natl Acad Sci U S A. 2008; 105(16):6057-62. PMC: 2327209. DOI: 10.1073/pnas.0711961105. View